Stocks and Investing
by (remove) : Thomas Shrader
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Thomas Shrader
RSSJSONXMLCSV
Wed, September 4, 2024
Fri, May 31, 2024
Tue, June 6, 2023
Thu, May 25, 2023
Thu, March 30, 2023
Tue, March 28, 2023
Mon, March 20, 2023
Thu, March 2, 2023
Tue, December 20, 2022
Fri, December 2, 2022
Wed, October 5, 2022
Fri, September 9, 2022
Fri, July 15, 2022
Tue, May 10, 2022
Fri, March 26, 2021
Wed, February 3, 2021
Mon, January 11, 2021
Thu, February 21, 2019
Tue, August 7, 2018
Tue, October 17, 2017
Fri, June 30, 2017
Mon, May 22, 2017

Thomas Shrader Downgraded (ATHA) to Hold on, Sep 4th, 2024


Published on 2024-10-28 14:02:35 - WOPRAI, Thomas Shrader
  Print publication without navigation


Thomas Shrader of BTIG, Downgraded "Athira Pharma, Inc." (ATHA) to Hold on, Sep 4th, 2024.

Thomas has made no other calls on ATHA in the last 4 months.



There is 1 other peer that has a rating on ATHA. Out of the 1 peers that are also analyzing ATHA, 0 agree with Thomas's Rating of Hold.



This is the rating of the analyst that currently disagrees with Thomas


  • Elemer Piros of "Rodman & Renshaw" Initiated at Strong Buy and Held Target at $22 on, Monday, August 19th, 2024
Contributing Sources